Sale

Infertility Drugs Market

Global Infertility Drugs Market Size, Share, Growth, Forecast: By Drug Class: Clomiphene Citrate, Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, Others; By Gender; By Route of Administration; By Distribution Channel; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032

Global Infertility Drugs Market Outlook

The global infertility drugs market is expected to grow at a CAGR of 6.20% in the forecast period of 2024-2032.

 

Global Infertility Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Gonadotrophins Segment Based on Drug Class Holds a Significant Share in the Global Infertility Drugs Industry

The gonadotrophins segment based on drug class accounts for a significant share in the market owing to the ability of gonadotrophins to ameliorate the chances of women being pregnant. A single gonadotrophin injection can stimulate the ovaries of women to produce follicles, which contain egg.

In addition to this, women are becoming more aware about reduced side-effects associated with gonadotrophins. Hence, the segment accounts for a significant share in the market and is expected to witness a considerable growth in the coming years.

 

North America Accounts for a Significant Share in the Market

According to a research study, there is an increase in the number of  couples in North America and Europe who are trying to conceive and are facing the risk of infertility . This is mainly due to the hectic and busy lifestyles  of people in countries like the United States and Canada. In some of the states in the US, insurance policies also cover the costs of infertility treatment. This is driving the growth of the infertility drugs industry in North America. In addition to this, the thriving pharmaceutical industry in the region, coupled with highly trained doctors in hospitals and clinics, is one of the key factors driving the market growth in the region.

 

Infertility Drugs: Market Segmentation

Infertility drugs are drugs that are used to boost fertility among men and women who have difficulty getting pregnant. Infertility drugs are usually prescribed by doctors to stimulate ovulation in women and promote the production of healthy sperm among men.

 

Global Infertility Drugs Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on drug class, the market can be segmented into:

  • Gonadotrophins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

The significant end users of the product include:

  • Male
  • Female

The segmentation of the market, on the basis of distribution channel, is as follows:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Infertility Drugs Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Cases of Infertility among Men and Women to Boost the Growth of the Infertility Drugs Industry

The global infertility drugs industry is driven by the rising cases of infertility globally, or difficulty carrying a pregnancy to term. Certain medical conditions among men and women,  such as diabetes, cystic fibrosis, testicular failure, hormonal disorders, menopausal disorders, urinary infections, endometriosis, pelvic inflammatory disease (PID), and ovarian cysts, among others, can lead to infertility. The surge in the cases of these disorders can be attributed to unhealthy lifestyles and changing dietary habits, including smoking, anabolic steroid use, stress, obesity, and others, thereby contributing to the demand for infertility drugs . In addition, the market is anticipated to be supported by the development of advanced infertility treatment laboratories in emerging economies owing to the increased healthcare expenditure by the governments. This is expected to aid the market in the forecast period.

 

Key Industry Players in the Global Infertility Drugs Market

The report gives a detailed analysis of the following key players in the global infertility drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Merck KGaA
  • Abbott Laboratories
  • Mankind Pharma
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter’s five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Gender
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Clomiphene Citrate
  • Gonadotropins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Dopamine Agonists
  • Others
Breakup by Gender
  • Male
  • Female
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Merck KGaA
  • Abbott Laboratories
  • Mankind Pharma
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Thermo Fisher Scientific, Inc.
  • Genea Biomedx
  • IVFtech ApS
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Infertility Drugs Market Overview 

    3.1    Global Infertility Drugs Market Historical Value (2017-2023) 
    3.2    Global Infertility Drugs Market Forecast Value (2024-2032)
4    Global Infertility Drugs Market Landscape
    4.1    Global Infertility Drugs Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Infertility Drugs Product Landscape
        4.2.1    Analysis by Drug Class
        4.2.2    Analysis by Gender
        4.2.3    Analysis by Route of Administration
        4.2.4    Analysis by Distribution Channel
5    Global Infertility Drugs Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Infertility Drugs Market Segmentation 
    6.1    Global Infertility Drugs Market by Drug Class
        6.1.1    Market Overview
        6.1.2    Clomiphene Citrate
        6.1.3    Gonadotropins
        6.1.4    Aromatase Inhibitors
        6.1.5    Selective Estrogen Receptor Modulators (SERMs)
        6.1.6    Dopamine Agonists
        6.1.7    Others
    6.2    Global Infertility Drugs Market by Gender
        6.2.1    Market Overview
        6.2.2    Male
        6.2.3    Female
        6.2.4    Others
    6.3    Global Infertility Drugs Market by Route of Administration
        6.3.1    Market Overview
        6.3.2    Oral
        6.3.3    Parenteral
        6.3.4    Others
    6.4    Global Infertility Drugs Market by Distribution Channel
        6.4.1    Market Overview
        6.4.2    Hospital Pharmacy
        6.4.3    Retail Pharmacy
        6.4.4    Online Pharmacy
        6.4.5    Others
    6.5    Global Infertility Drugs Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Infertility Drugs Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Infertility Drugs Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Infertility Drugs Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Infertility Drugs Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Infertility Drugs Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Clinical Trials Analysis
    14.1     Analysis by Trial Registration Year
    14.2    Analysis by Trial Status
    14.3    Analysis by Trial Phase
    14.4    Analysis by Therapeutic Area
    14.5    Analysis by Geography
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Supplier Landscape
    18.1    Merck KGaA
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    Abbott Laboratories
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Mankind Pharma
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Pfizer Inc.
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Ferring Pharmaceuticals Inc.
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Thermo Fisher Scientific, Inc.
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Genea Biomedx
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    IVFtech ApS
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
19    Global Infertility Drugs Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market is estimated to grow at a CAGR of 6.20% between 2024 and 2032.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising cases of infertility among men and women, improving healthcare facilities, growing awareness, and the establishment of advanced infertility treatment laboratories, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing FDA approval of new and efficient infertility drugs.

Gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and biguanides, among others are the different segments based on drug class.

Male and female are the different end users considered within the market report.

Hospital pharmacies and retail pharmacies, among others are the different distribution channels of infertility drugs.

The major players in the industry are Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others.

Analyst Review

The global infertility drugs market is being driven by the rising cases of infertility among men and women. Aided by the rising investments to develop advanced infertility treatment laboratories, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.20%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the market is divided into gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and biguanides, among others. On the basis of end user, the market is divided into male and female. The major distribution channels of the product are hospital pharmacies and retail pharmacies, among others. The major regional markets for infertility drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others. 

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER